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Clinical management of short bowel syndrome remains a multistage process. Although PN is crucial, early introduction of enteral
feeding is mandatory. We describe retrospectively 4 patients with an ultrashort bowel who could be weaned oﬀ PN on very short
terms after introduction of an amino-acid-based formula (Neocate). Patient 1 had congenital short bowel with 50cm small bowel
and 30cm colon. He had persistent diarrhoea on a semielementary formula. When Neocate was introduced he could be weaned
from PN within 6 months. Patient 2 needed multiple surgical interventions because of NEC at D 27. He maintained 40cm small
bowelandanintactcolonandremainedPNdependentonsemielementalformula.AfterintroducingNeocate,PNcouldbeweaned
within 3 months. In the next 2 patients, Neocate was introduced as initial enteral feeding after bowel resection following antenatal
midgut volvulus. Patient 3 had 20cm small bowel and an intact colon. PN was weaned after 2 months. Patient 4 had 9cm small
bowel and an intact colon. PN was weaned after 13 months. In all patients Ileocaecal valve (ICV) was preserved. No consensus is
reached on the type of formula to use for short bowel syndrome. Compared to recent data in the literature, the weaning period
in these 4 patients was signiﬁcantly shortened on an aminoacid based formula. The reason for this may lie in the antiallergic
properties of this formula. We recommend the use of an amino-acid-based formula to induce earlier weaning of PN.
1.Introduction
Short Bowel Syndrome (SBS) is the most common cause of
protracted intestinal failure. About 85%–94% of SBS infants
survive the neonatal period [1]. Even though the causes
of SBS are diverse, the management has identical pillars:
parenteral nutrition (PN) and early enteral nutrition (EN).
Prognosis is associated with age-adjusted small bowel
length, the presence of the ileocaecal valve (ICV) and
colon, the advent of PN complications, and the capacity
of the remaining intestine to adapt [2]. Several hormonal
and surgical methods to improve bowel adaptation have
been reported [3–8], but EN remains an important and
controllable factor. Direct trophic eﬀect of nutrients and
stimulation of gastrointestinal secretions and hormonal
factors enhances intestinal adaptation [3, 6, 8]. We present
4 cases of ultrashort bowel syndrome (<40cm residual small
bowel) (Table 1) rapidly weaned of PN after introduction of
an elemental formula (Neocate, Nutricia, Strombeek-Bever,
Belgium). Neocate is the only elemental formula available
in Belgium. Table 2 illustrates the composition of Neocate
compared to other elemental formulas available in other
countries and to the semi-elementary formula used in
2/4 patients. All patients received a PPI (Omeprazole) as
additional medication as part of the SBS treatment [9].
2.CaseReports
2.1. Patient 1. The diagnosis of congenital short bowel in
Patient 1 was made by explorative laparotomy at the age of
3 months. He had no Treitz angle, a small bowel of 50cm,
and a colon of 30cm length. Postoperatively, he received
PN. EN with semi-elemental formula was started following
the EN scheme used in our department as illustrated in
Table 3. He was discharged from the hospital at 8 months. A
third of his calories was tolerated by continuous EN through
a gastrostomy (43kcal/kg/d), and home PN was organised
for the remaining caloric requirements (86kcal/kg/d). The
advancement of EN was limited by recurrent profuse2 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
Table 1: Shows for every patient the residual small bowel length
(RSBL = residual length of the small intestine measured perop-
eratively along the antimesenteric border), the age at the start of
Neocate (N), the age of complete PN, weaning and the total time on
PN. In all patients the ileocaecal valve and colon were present. m =
months; d = days.
Start N Stop PN Total PN RSBL
Patient 1 36m 44m 8m 50cm
P atient2 4m 7m 3m 32cm
Patient 3 19d 2m 1m 11d 20cm
Patient 4 12d 13m 12m 18d 10cm
diarrhoea, and at 3 years of age, Neocate was introduced.
He was started at 1/3 of his daily requirements (total cals:
130kcal/kg/d) on continuous enteral infusion and upgraded
following Table 2. Step 2 was reached 8 months later and PN
could be discontinued. After initial PN weaning, the patient
needed another 5 days of TPN during an episode of D-
lactate acidosis with severe dehydration. He was started on
probiotics (VSL3: 450 bilion lactic acid bacteria per package
in deﬁned ratios of biﬁdobacterium breve, biﬁdobactium
longum, biﬁdobacterium infantis, lactobacillus acidophilus,
lactobacillus plantarum, lactobacillus paracasei, lactobacillus
bulgarius,streptococcusthermophilusbyVSLPharmaceuticals,
Inc.) and remains well since. Introduction of soy and
cow’s milk protein was tried at 6 years. Although RAST
testing remained negative, serum albumin dropped, and the
patient stopped growing for 12 months (25th percentile to
10th percentile). Biochemistry and growth, following the
10th percentile, recovered on reintroduction of Neocate.
Presently, the boy is 9 years old. He remains on step 4 of
the weaning scheme (Table 2) receiving 46% of his calories
by nocturnal feeds (1500mL neocate 20% + 20g protifar =
1527kcal/58.5gEW/69.2gV/168gKH), and reintroduction
of cow’s milk and soy protein is planned. His motor
development is normal, and his growth parameters (height
and weight) follow the 10th percentile.
2.2. Patient 2. P a t i e n t2w a sb o r na t2 5w e e k sg e s t a t i o n ,
with a birth weight of 700g and suﬀered severe enterocolitis
at day 27. It led to resection of a large part of the small
bowel. A second look operation revealed 32cm of small
bowel remaining to re-establish continuity. The ICV and
colon were preserved. Several attempts to start and increase
EN with semi-elemental formula (Alfare, Nestle, Brussels,
Belgium) failed. The patient was transferred to our unit
at the age of 4 months. Continuous enteral feeding with
Neocate was started successfully in combination with PN
and oral stimulation (Table 2, step 1). At the age of 5
months, she developed severe diarrhoea and abdominal
distension. A proximal jejunal stenosis was repaired with
minimal bowel resection. Five days after surgery, EN was
restarted and successfully upgraded following Table 1.P N
was stopped 3 months after the initiation of Neocate. The
patient reached step 2 (Table 2) when she left the hospital
at 8 months of age (total calories 128.4cal/kg/day). The
further follow-up was performed in the referring centre.
She obtained complete oral gastrointestinal autonomy at
the age of 1 year and has successfully been switched to
semi-elementalformula(Nutramigen,MeadJohnson,Braine-
L’alleud,BelgiumandFrisomel;FrieslandCobercoDairyfoods,
Meppel, the Netherlands). She is treated with a proton
pomp inhibitor because of severe gastroesophageal reﬂux.
Her growth is normal (weight 10th percentile, height 10th–
25th percentile), and her vitamin status and electrolytes are
checked regularly and are within the normal range without
supplements.
2.3. Patient 3. Patient 3, born at 33 weeks, 1700g, had dark
gastric aspirates ﬁve days after birth. An urgent laparotomy
showed a midgut volvulus. A large bowel resection left 12cm
of jejunum and 8cm of ileum with an intact colon and a
preserved ICV. Postoperatively the patient received total PN.
EN with Neocate was started 14 days after surgery following
Table 2. At the age of 2 months, the patient tolerated full EN
on Neocate 20% (step 2, Table 2). A gastrostomy was placed,
and PN was discontinued. At discharge, he was on daytime
boluses and night-time continuous feeding (step 3a Table 2)
whichwereadaptedweeklyfollowingtolerance(totalcalories
142cal/kg/day,10%po,90%ps).Heachievedoralautonomy
(step 4 Table 2) at 6 months, and solids were introduced.
His oral caloric intake from Neocate remained 93cal/kg/day.
By that time, the patient caught up in length and weight,
reaching normal growth percentiles (3rd percentile) for his
age.
2.4. Patient 4. In patient 4, a duplicature of the stomach was
suspectedonprenatalultrasound.Bornatterm,theamniotic
ﬂuid was meconium stained, the abdomen was dilated, and
vital signs were compromised. An explorative laparotomy
showed necrotising small bowel with hemorrhagic ﬂuid,
suggestingprenatalvolvulus.Extensiveresectionwasneeded,
leaving 5cm of duodenum, 4cm of terminal ileum, the ICV,
and the colon. Postoperatively TPN was initiated. On day 12,
continuous enteral feeding with Neocate following Table 2
was started. A gastrostomy was placed at the age of 1 month.
When she was discharged home at the age of 3 months, the
gastrostomy had been removed due to peritonitis, and she
wasfedbysmalloralbolusesofNeocate20%(6×20mL)and
nightly PN (130kcal/kg/d, 36% po and 64% PN). Although
she made good progress with oral Neocate, growth deviation
from the 50th to the 25th percentile indicated the need for
extra support and nocturnal feeding through a gastrostomy
at 11 months. Two months later PN was discontinued.
The patient maintained her growth with oral intake and
supplemental enteral feeding (Total 121.5kcal/kg/d, 73.5%
po and 26.5% ps) (step 4 Table 2).
Frequent liquid stools without reducing substances were
debilitating and persisted despite trials of Cotrimoxazole,
cholestyramin, and probiotics. Stools normalised sponta-
neously over time. The patient is now 3.5 years old. She
eats a varied diet during the day and has nightly enteral
supplements with Neocate (Total 121.5kcal/kg/d, 48% po
and52%ps,4.9gprot/kg/d)(step4,Table 2).Cow’smilkandJ o u r n a lo fN u t r i t i o na n dM e t a b o l i s m 3
Table 2: Composition of the 3 commercialised elemental infant formulas and the hydrolized formula used in 2/4 patients. ∗Nutricia,
Strombeek-Bever, Belgium, ∗∗Sandoz Nutrition Corporation, Minneapolis, US; †Abbot Nutrition, Illinois, US; ‡Nestle, Brussels, Belgium.
Neocate∗ Vivonex Pediatric∗∗ Elecare† Alfare‡
Kcal 100 100 100 100
Protein (g) 3.1 33 . 1 3
Fat (g) 4.5 2.9 4.8 5.08
%MCT 5% 68% 33% 40%
Carbohydrates (g) 11.7 15.5 10.7 10.92
VITAMINS
Vit A (IU) 409 312.5 273 350
Vit D (IU) 59.9 62.5 42 60
Vit E (IU) 1.14 3.7 2.1 2.5
Vit K (mcg) 8.7 56 8
Thiamin (mcg) 92.6 190 210 70
Riboﬂavin (mcg) 137.8 225 105 150
Vit B6 (mcg) 123.5 250 84.2 80
Vit B12 (mcg) 0.26 0.37 0.4 0.3
Niacin (mcg) 1544 2500 1680 1000
Folic Acid (mcg) 10.2 25 29.5 9
Pantothenic Acid (mcg) 620 625 421 450
biotin (mcg) 3.1 12.5 4.2 2
Vit C (mg) 9.2 12.5 9 10
Choline (mg) 13.1 25 9.5 10
Inositol (mg) 23.3 7.5 5.1 5
MINERALS
Calcium (mg) 124 121.5 116 77
Phosphorus (mg) 93.1 100 84.2 52
Magnesium (mg) 12.4 25 8.4 12
Iron (mg) 1.85 1.25 1.5 1
Zinc (mg) 1.66 1.5 0.8 1
Manganese (mcg) 90 250 84 7
Copper (mcg) 124 150 105 80
Iodine (mg) 15.4 15 8.4 15
Selenium (mcg) 3.7 3.7 2.3 3.5
Chromium (mcg) 3.5 5.6 2.3
Molybdene (mcg) 4.7 9.4 2.5
Sodium (mg) 37.3 50 45 50
Potassium (mg) 155.1 150 150 125
Chloride (mg) 77.2 125 60 90
soy are excluded from her diet because of clinical intolerance
and elevated RAST tests.
She was toilet trained at 30 months and has normal
motor development and growth (weight 50th percentile,
height 25th percentile).
3. Discussion
SBS is deﬁned as malabsorption and failure to thrive follow-
ing extensive resection of the small bowel. Surgical classiﬁ-
cation of SBS is based on the residual length of the small
intestine measured peroperatively along the antimesenteric
border. Although residual length is an important element,
it is not the only prognostic factor. The adaptive capacity
of the remaining gut is a major component for obtaining
enteral autonomy. Enteral autonomy and PN weaning while
maintaining adequate growth are the principal endpoints in
this group of patients. Early introduction of EN is universally
recommended. The scheme for EN used in our centre is
illustrated in Table 3. Continuous enteral feeding is the
startingmethodofchoiceasitenhancesintestinalabsorption
and improves tolerance [10]. Concentration of the con-
tinuous feed is progressively increased until total caloric
requirements are tolerated. Only then, PN is discontinued,
andbolusfeedinginitiated.Enteraltoleranceismonitoredby
intake, growth, stool frequency, stool consistency, reducing
substances,andbiochemistry. Threeofthe4infantsreported4 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
Table 3: EN scheme used and validated in our department.
Step 1.a
Day Night
Oral stimulation (ORS) + + + +
E n t e r a lN u t r i t i o n :c o n t i n u o u s( N e o c a t e ) — ∗ —∗ —∗ —∗ —∗
Parenteral Nutrition: Continuous — — — — —
Step 1.b
Day Night
Oral stimulation (ORS) + + + +
E n t e r a lN u t r i t i o n :c o n t i n u o u s — ∗ —∗ —∗ —∗ —∗
Parenteral Nutrition —
Step 2
Day Night
Oral stimulation (ORS) + + + +
E n t e r a lN u t r i t i o n :c o n t i n u o u sN e o c a t e2 0 % — — — — —
Step 3.a
Day Night
Oral Nutrition (Neocate) — — — —
E n t e r a lN u t r i t i o n :d a i l yb o l u s e s — — — — —
Nocturnal continuous
Step 3.b
Day Night
Oral Nutrition (diverse) — — — —
Enteral Nutrition: daily boluses (Neocate) — — — — —
Nocturnal continuous
Step 4
Day Night
Oral Nutrition (diverse) — — — —
Enteral Nutrition: daily boluses (Neocate) — — — —
OR
Day Night
Oral Nutrition (diverse) — — — —
Enteral Nutrition: Nocturnal continuous —
Step 5
Day Night
Oral Nutrition — — — —
Step 6
Diversiﬁcation oral nutrition
∗Progressive increase in concentration, 13%–15%–17%–20% until tolerance for total caloric requirements and growth are obtained.
have an ultrashort gut (<40cm), and one has a congenital
short bowel of 50cm, in which function is known to
be altered [11]. All patients needed parenteral nutrition,
but enteral autonomy was obtained and maintained rela-
tively rapidly (<13 months) after introduction of Neocate
(Table 1).
Georgeson and Breaux [12] retrospectively described
a group of 52 SBS patients receiving an elemental diet.
Residual bowel length in 21/52 was <40cm. PN weaning was
obtained in 12/21, and the mean weaning period was 24.1
months. Not all patients could be weaned oﬀ PN, but the
majority of this group had no ICV (17/21). Recurrence of
PN after initial weaning was not recorded. More recently,
Goulet et al. [1] reported 78 SBS patients, receiving initially a
hydrolyzed diet, followed up for 15 years. Ultrashort bowel,
<40cm, was seen in 21/78 patients. In 9 patients (42.8%) PN
weaning failed, and in the 12 patients remaining (57.2%),
enteral or parenteral support was necessary after initial PN
weaning. Initial PN duration in those 12 patients was 47.4 ±
23.8 months. The weaning period in Georgeson’s study was
considerably shorter with an elemental diet compared with
Goulets’ group, receiving a semi-elemental diet (24.1 versus
47.4 months).
There is no agreement in literature on what formula to
use in SBS infants. Semi-elemental or elemental formulas
are most frequently started [1, 6]. Where some studiesJ o u r n a lo fN u t r i t i o na n dM e t a b o l i s m 5
suggest that a more complex diet with long chain fat (LCF)
and complex carbohydrates enhances adaptation [13–15],
others support the important inﬂuence of an elemental
diet on the weaning of PN and enteral tolerance [16].
The ﬁrst 2 patients described in our series failed to thrive
on a hydrolyzed formula as did 4 patients reported by
B i n e se ta l .[ 17]. Enteral autonomy was obtained after
introduction of elemental formula in all 6 patients. Although
theratioisdiﬀerent,bothhydrolyzedandelementalformulas
contain LCF and complex carbohydrates. Therefore, another
contributing factor needs to be considered: the elimination
of a certain allergen or the presence of a yet unidentiﬁed
stimulating substance [17].
Many children acquire SBS at a very young age; it makes
them naturally prone for cow’s milk intolerance (CMI). In
infants, cow’s milk protein is the most frequent allergen.
Generally,CMI is considered to be 2%-3% below the age of
2y e a r s[ 18], but there is no exact data about the incidence of
CMI and food allergy in SBS patients, except for small case
series [16, 17].
An alteration in gut permeability, often present in SBS
patients, can be a predisposing factor. First of all, the
administration of TPN without enteral support increases
intestinal permeability, whereas the administration of even
small amounts of EN can reverse this process [19]. Bacterial
overgrowth on the other hand, a common complication of
SBS, inﬂuences gut permeability through local gut inﬂam-
mation [20].
We think that the combination of these factors might
make SBS patients more prone for CMI. In 2 of our patients
(patient 1 and 4), even the late introduction of cow’s
milk protein failed. This is an additional argument for the
contribution of CMI to their initial feeding intolerance and
explains the success of Neocate in these patients.
Only 1 study compared intestinal permeability in SBS
patients in a crossover study with hydrolized and whole
protein formula [15]. Ten patients were included when 30%
of enteral nutrition was tolerated, and no diﬀerence in
intestinalpermeabilitywasfound.Althoughmeasurementof
intestinal permeability in this patient group while investigat-
ing tolerance to diﬀerent formulas is of interest, no comment
was made about PN weaning, 30% of enteral nutrition had
to be tolerated before inclusion, the study period was rather
short (60 days), and no washout period in between formulas
was considered.
Becauseofaparentalchoice,noneofthepatientsreceived
breast milk.CMI develops less frequently in breastfed babies,
andbreastmilkhastheadditional trophic eﬀectofprobiotics
and growth factors on the intestinal mucosa, beneﬁcial to
SBS patients [8, 18]. Unfortunately, continuous feeding and
increasing calories with breast milk can be more challenging.
We realise that, even after reporting these 4 cases, the
publisheddataabouttherelationshipbetweenresidualbowel
length, bowel adaptation, formula,CMI, and PN weaning
remain scarce. In all our patients ICV and colon were
preserved,whichincreasesthechanceofdeﬁnitePNweaning
[1, 2, 6].
Evidence from randomised controlled trials (RCTs) on
this subject is lacking. Because of limited patient numbers,
large RCTs are diﬃcult to perform in a single centre and a
multicentreapproachisnecessary.Measurementofintestinal
permeability, growth, allergic parameters, and PN duration
should be included.
If breast milk is not an option, we would recommend an
amino-acid based formula as the initial enteral feeding for
SBS infants. It may lead to reduction in PN duration, cost,
and complications and beneﬁt the patients’ quality of life.
Despite all, it remains important as a doctor to focus on the
outcome for the patient and to continue investigating if the
initial treatment fails.
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